Nfl Biosciences: Half-Year Review of the Liquidity Agreement for h2 2021
NFL BIOSCIENCESHALF-YEAR REVIEW OF THE LIQUIDITY AGREEMENT FOR H2 2021 Under the liquidity agreement concerning NFL Biosciences SA shares (FR0014003XT0...
Day: January 12, 2022
Zhittya Genesis Medicine Starts Parkinson’s Disease Clinical Trial
LAS VEGAS, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that it is...
First Stop Health Launches Virtual Primary Care to Treat Urgent, Preventive and Chronic Care Issues
Virtual Primary Care gives members convenient, fast and affordable access to high-quality care while helping to lower healthcare costs for...
Movement Industries Corporation (OTC: MVNT) Provides 2021 Recap and 2022 Outlook
Company Reviews Highlights and Next Steps Houston, TX, Jan. 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Movement Industries Corporation...
ACT Foundation recognizes Amgen Canada with Community Champion Award
Amgen Canada proud supporter of the ACT High School CPR and AED program Amgen Canada’s Brian Heath, Vice President and...
Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022
New York, NY, and Tel Aviv, ISRAEL, Jan. 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF),a comprehensive medical...
MiNK Therapeutics to Participate at Upcoming B. Riley Securities Virtual Oncology Conference
NEW YORK, Jan. 12, 2022 (GLOBE NEWSWIRE) -- MiNK Therapeutics, a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization...
Vaxxinity Announces First Parkinson’s Disease Patient Dosed in Part B of Phase 1 Clinical Trial of UB-312
DALLAS, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new...
Chronus Health Raises $22 Million in Series A Financing to Accelerate Development of Portable, Rapid Blood Analyzer Technology
Company poised to disrupt $80 billion U.S. clinical laboratory marketMOUNTAIN VIEW, Calif., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Chronus Health,...
Intuitive Announces Preliminary Fourth Quarter and Full Year 2021 Results
SUNNYVALE, Calif., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive...
Wellframe Achieves Momentous Growth in 2021, Accelerating Its Ability to Modernize the Member Experience
The Boston-based company concludes the year with a 100% year over year revenue growth that further accelerates its commitment to...
Pure Extracts Signs White Label Agreement with West Coast Licensed Producer
VANCOUVER, British Columbia, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
Jennifer Aniston partners with Idorsia U.S. to launch ‘Seize the Night & Day’ campaign inspiring Americans to understand their relationship with sleep
Jennifer Aniston partners with Idorsia U.S. to launch ‘Seize the Night & Day’ campaign inspiring Americans to understand their relationship...
Sharps Compliance Announces Second Quarter Fiscal 2022 Conference Call and Webcast
HOUSTON, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) announced today that it will release its second...
Tenax Therapeutics Granted U.S. Patent for the Subcutaneous Use of Levosimendan (TNX-102)
Provides Broad Coverage for Use of TNX-102 for the Treatment of Human Subjects with Any Health Condition Patent Term to 2039,...
Antares Pharma Appoints Claude E. Richardson as Senior Vice President of Human Resources
EWING, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, announced...
Myovant Sciences to Host Third Fiscal Quarter 2021 Earnings Conference Call at 8:30 a.m. Eastern Time on January 26, 2022
BASEL, Switzerland, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women...
Athenex Announces Agreement with ImmunityBio Regarding Dunkirk Manufacturing Facility
BUFFALO, N.Y., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery,...
Artelo Biosciences Reports First Quarter Fiscal Year 2022 Financial Results and Provides Business Update
Complete Enrollment of Phase 1 CAReS Trial Anticipated by End of First Quarter of Calendar Year 2022 $26.4 Million in...
Lixte Biotechnology Announces Filing of First Patent Application Resulting from Collaboration with the Netherlands Cancer Institute and the Oncode Institute to Identify the Most Promising Drug Combinations for Lead Clinical Compound, LB-100
PASADENA, CA, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) reported that its the recent collaboration with the...
